scorecardresearch
Tuesday, July 29, 2025
TopicCancer treatment

Topic: Cancer treatment

SubscriberWrites: The Tightrope of Breaking Bad News

A dilemma between hope and honesty

How cancer daycare centres promised in Budget 2025 aim to ease treatment costs, access

Cancer care in India is marked by barriers of access & disparities in availability of quality care. Daycare centres at district hospitals could save patients up to Rs 10,000 cr annually.

After Sidhu claims diet changes helped his wife beat cancer, doctors warn against unscientific cures

Navjot Singh Sidhu says his wife, diagnosed with stage 4 breast cancer, followed a diet that included neem, turmeric, sour fruits. Oncologists say complementary therapies not treatment.

India relied on Western data for cancer care. Now, a platform pulls data from Indian patients

Definite steps are now being taken to understand the profile of cancer in the Indian population. Expect rapid progress in cancer care in India in the coming years.

Don’t let foreign big pharma block biosimilars. Govt should boost access in India

Without widespread access to biosimilars, thousands of cancer patients are losing their battle. Life-saving treatment is not a privilege but a right. The government should understand this.

India gets 1st homegrown CAR T-cell therapy centre at IIT-B. All about breakthrough cancer treatment

CAR T-cell therapy's a form of immunotherapy that uses body's immune cells called T-cells, a type of lymphocyte or white blood cell. It has been approved for various types of blood cancers.

Pill under Rs 100 to reduce cancer recurrence? Novel nutraceutical holds promise but it’s too early

Findings by Tata Memorial Centre suggest that resveratrol, when given with miniscule doses of copper, can reduce rate of metastasis & treatment-related toxicity in cancer patients.

All about India’s 1st ‘living drug’ that uses patient’s own genetically engineered cells to fight cancer

Patients already registering for CAR T-cell therapy, developed indigenously by ImmunoACT under the name NexCAR19. It will be used to treat leukemia & refractory or relapsed lymphoma.

Combination of 2 immunotherapy drugs can help liver cancer patients live longer, finds India study

Done by researchers from Hyderabad's Asian Institute of Gastroenterology & Jaipur's Mahatma Gandhi Medical College, study was published in 'Journal of Clinical & Experimental Hepatology'.

Tata Memorial Centre-led project makes waves with promise to cut cancer drug costs by up to 99%

23 hospitals from National Cancer Grid, a network of over 250 cancer centres, pilot ‘pooled procurement’ to improve negotiability for high-value oncology and supportive-care drugs.

On Camera

No other city is like Gurugram—’so mismanaged, yet so highly spoken of’

Gurugram has a problem of structural abandonment, whether you’re a domestic worker speaking an alien language, or the much-celebrated CEO of the new hot startup.

Govt’s earlier FDI limit of 74% in insurance sector has remained underutilised, Parliament told

In the latest budget, the FDI limit was increased to 100 percent, but most foreign companies are not buying such large stakes in the Indian insurance sector.

India wanted a stable, prosperous Pakistan but our peace efforts were mistaken for weakness: Rajnath

Modi government had also made numerous efforts to establish peace with Pakistan but has now adopted a different path, militarily, to establish peace, adds defence minister.

Modi’s Bharat vs Indira’s India: 11-yr report card of politics, diplomacy, economy, nationalism

As Narendra Modi becomes India’s second-longest consecutively serving Prime Minister, we look at how he compares with Indira Gandhi across four key dimensions.